239 related articles for article (PubMed ID: 24998426)
21. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
23. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
[TBL] [Abstract][Full Text] [Related]
24. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA
Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
27. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
28. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
[TBL] [Abstract][Full Text] [Related]
29. A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.
Kasamatsu H; Chino T; Hasegawa T; Utsunomiya N; Utsunomiya A; Yamada M; Oyama N; Hasegawa M
Arthritis Res Ther; 2023 Aug; 25(1):156. PubMed ID: 37626391
[TBL] [Abstract][Full Text] [Related]
30. MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.
Ciechomska M; O'Reilly S; Suwara M; Bogunia-Kubik K; van Laar JM
PLoS One; 2014; 9(12):e115596. PubMed ID: 25549087
[TBL] [Abstract][Full Text] [Related]
31. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
Tamaki Z; Asano Y; Kubo M; Ihn H; Tada Y; Sugaya M; Kadono T; Sato S
J Dermatol Sci; 2014 Jun; 74(3):251-9. PubMed ID: 24630239
[TBL] [Abstract][Full Text] [Related]
32. Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress.
Chu H; Shi Y; Jiang S; Zhong Q; Zhao Y; Liu Q; Ma Y; Shi X; Ding W; Zhou X; Cui J; Jin L; Guo G; Wang J
Sci Rep; 2017 May; 7(1):2252. PubMed ID: 28533545
[TBL] [Abstract][Full Text] [Related]
33. Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.
Luong VH; Chino T; Oyama N; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Biswas T; Hamasaki A; Fujita M; Okamoto Y; Otsuka M; Ihn H; Hasegawa M
Arthritis Res Ther; 2018 Mar; 20(1):46. PubMed ID: 29544542
[TBL] [Abstract][Full Text] [Related]
34. Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma.
Bhattacharyya S; Chen SJ; Wu M; Warner-Blankenship M; Ning H; Lakos G; Mori Y; Chang E; Nihijima C; Takehara K; Feghali-Bostwick C; Varga J
Am J Pathol; 2008 Oct; 173(4):1085-99. PubMed ID: 18772333
[TBL] [Abstract][Full Text] [Related]
35. Anti-fibrotic effects of Astragaloside IV in systemic sclerosis.
Qi Q; Mao Y; Yi J; Li D; Zhu K; Cha X
Cell Physiol Biochem; 2014; 34(6):2105-16. PubMed ID: 25562158
[TBL] [Abstract][Full Text] [Related]
36. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
[TBL] [Abstract][Full Text] [Related]
38. Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment.
Higuchi T; Takagi K; Tochimoto A; Ichimura Y; Norose T; Katsumata Y; Masuda I; Yamanaka H; Morohoshi T; Kawaguchi Y
Arthritis Res Ther; 2019 Apr; 21(1):103. PubMed ID: 30999934
[TBL] [Abstract][Full Text] [Related]
39. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
François A; Chatelus E; Wachsmann D; Sibilia J; Bahram S; Alsaleh G; Gottenberg JE
Arthritis Res Ther; 2013 Oct; 15(5):R168. PubMed ID: 24289101
[TBL] [Abstract][Full Text] [Related]
40. Salvianolic Acid B Attenuates Experimental Pulmonary Fibrosis through Inhibition of the TGF-β Signaling Pathway.
Liu Q; Chu H; Ma Y; Wu T; Qian F; Ren X; Tu W; Zhou X; Jin L; Wu W; Wang J
Sci Rep; 2016 Jun; 6():27610. PubMed ID: 27278104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]